Chris Carroll BA, MA (King's College London), MSc (Sheffield), PhD (Cambridge)
Reader in Systematic Review and Evidence Synthesis
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA
Office: 112 West Court
Tel: (+44) (0)114 222 0864
Fax: (+44) (0)114 222 0749
I joined ScHARR in 2004 and was appointed as a Research Fellow in 2007. In early 2011 I was appointed Senior Lecturer in Health Technology Assessment (HTA) and was the first Course Director of the MSc in International Health Technology Assessment, Pricing and Reimbursement (iHTA), with responsibility for developing and running the programme. The MSc is now in its ninth year. In 2014 I was promoted to Reader and made a University Senate Fellow for Excellence in Learning and Teaching. I stepped down as Course Director of the iHTA programme in 2015 and returned to working for the ScHARR Technology Assessment Group (TAG) conducting appraisals for NICE (2015-2018). I was previously the Lead for the systematic reviewers in HEDS (2017-18), and in 2018 was appointed Deputy Director of Health Economics and Decision Science and the REF Co-ordinator for the School (Unit of Assessment 2).
- Systematic review and evidence synthesis of medical, health and social science topics, including qualitative and mixed method evidence synthesis;
- The Health Technology Assessment (HTA) process and related decision-making;
- Research on research: research impact and the analysis of evidence informing healthcare decision-making;
- Information retrieval and programme evaluation (implementation fidelity) research
- I am interested in supervising research students in topics/areas such as systematic review and evidence synthesis methods, the health technology assessment (HTA) process, and implementation research.
- A qualitative evidence synthesis of the views and preferences of parents, family, health professionals and decision-makers regarding infant feeding in the context of infectious disease transmission risk. WHO commissioned (PI).
- A qualitative evidence synthesis of the feasibility, acceptability, accessibility, sustainability and cost implications of Ready-to-Use-Therapeutic Foods (RUFT) with <50% proteins from milk products for uncomplicated severe acute malnutrition (SAM) in infants aged 6 months or older. WHO commissioned (PI: Andrew Booth).
- Member of the NICE Interventional Procedures Advisory Committee (IPAC) 2014-2020
- Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. The Lancet Infectious Diseases, 20(1), e2-e10. View this article in WRRO
- Decision‐making by the NICE Interventional Procedures Advisory Committee. BJS (British Journal of Surgery). View this article in WRRO
- Qualitative evidence synthesis to improve implementation of clinical guidelines. BMJ, 356. View this article in WRRO
- Quality assessment of qualitative evidence for systematic review and synthesis: Is it meaningful, and if so, how should it be performed?. Research Synthesis Methods, 6(2), 149-154. View this article in WRRO
- Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.. Br J Surg, 101(9), 1040-1052. View this article in WRRO
- "Best fit" framework synthesis: refining the method.. BMC Med Res Methodol, 13, 37. View this article in WRRO
- A qualitative evidence synthesis of employees' views of workplace smoking reduction or cessation interventions.. BMC Public Health, 13, 1095. View this article in WRRO
- Should we exclude inadequately reported studies from qualitative systematic reviews? An evaluation of sensitivity analyses in two case study reviews.. Qual Health Res, 22(10), 1425-1434.
- A worked example of "best fit" framework synthesis: a systematic review of views concerning the taking of some potential chemopreventive agents.. BMC Med Res Methodol, 11, 29. View this article in WRRO
- A conceptual framework for implementation fidelity.. Implement Sci, 2, 40. View this article in WRRO